RJA
SLXP

Raymond James & Associates’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Raymond James & Associates’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,190
Closed -$1.59M – 2362
2014
Q3 		$1.59M Buy
10,190
+93
+0.9% +$14.5K 0.01% 1210
2014
Q2 		$1.25M Buy
+10,097
New +$1.25M 0.01% 1364